期刊
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
卷 18, 期 2, 页码 83-84出版社
NATURE RESEARCH
DOI: 10.1038/s41575-020-00399-w
关键词
-
资金
- Bachetta Foundation
Key studies in 2020 highlight that impaired intestinal barrier function precedes the clinical diagnosis of inflammatory bowel disease by years and could serve as a potential therapeutic target in the future.
Key studies published in 2020 demonstrate that an impaired intestinal barrier precedes clinical diagnosis of inflammatory bowel disease (IBD) by years. Furthermore, studies identify novel regulators of the intestinal barrier, including intestinal macrophages and diurnal variations of diet-microbiome interactions, which could be future therapeutic strategies for IBD. Key advances Intestinal barrier dysfunction precedes and predicts the development of Crohn's disease7,8. Macrophages in the distal colon in mice sense water and fungal metabolite absorption by intestinal enterocytes and regulate the intestinal barrier of the colon9. The small intestinal barrier in mice is regulated by diurnal variations in the diet-microbiome-enterocyte MHC-II-IL-10 axis in intraepithelial lymphocytes10.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据